In this project, we propose to continue our investigation of the biochemical and molecular mechanism(s) by which the regulation of glucose metabolism fails with aging. Such dysregulation is associated with impairments in insulin action on the muscle and liver, and a decreased ability to secrete insulin by the beta- cells of the pancreas. An increase in visceral/abdominal fat, more so than a general increase in fat mass, is a specific risk factor for a variety of conditions such as hyperlipidemia, hypertension and diabetes, resulting in increased cardio-vascular mortality with aging. We have previously characterized aging animal models that exhibit some of the metabolic features of human aging, and demonstrated a major cause/effect relationship between age-related changes in body composition and the impairment in hepatic and peripheral insulin action. Interestingly, longevity is increased in caloric restricted animal models, supporting the notion that fat mass has deleterious effects leading to mortality. Recently we discovered that the fat-derived peptide leptin regulates body fat distribution, in addition to its effect to increasing insulin action. We hypothesize that the typical increase in visceral/abdominal fat determines the impairment in glucose metabolism seen in aging. Furthermore, we suggest that aging is an """"""""leptin resistance"""""""" state, in which leptin fails to regulate body fat distribution and to maintain insulin action. We will test this hypothesis by preventing the increase in visceral/abdominal fat in rodents by caloric restriction or surgical removal of the visceral fat. We will study whether the age-related impairments in the molecular physiology of peripheral and hepatic insulin action, and in insulin secretion are thereby averted. Furthermore, we will determine if chronic leptin administration to aging rats will fail to regulate body fat distribution and insulin action. The effect of the changes induced in body composition on glucose metabolism, will be determined in vivo, and muscle, liver and pancreatic tissue will be analyzed to determine the relevant substrates, enzyme activities, and gene expressions after acute manipulations. This proposal is significant for determining the causal role that visceral fat has on the impaired glucose metabolism in aging, and the potential cause for this phenomenon. Once mechanisms for dysregulation of glucose metabolism are identified in animal models, interventions specifically designed to alter body composition in human aging may be proposed.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG018381-05
Application #
6794993
Study Section
Geriatrics and Rehabilitation Medicine (GRM)
Program Officer
Finkelstein, David B
Project Start
2000-09-01
Project End
2005-08-31
Budget Start
2004-09-01
Budget End
2005-08-31
Support Year
5
Fiscal Year
2004
Total Cost
$334,000
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
110521739
City
Bronx
State
NY
Country
United States
Zip Code
10461
Milman, Sofiya; Atzmon, Gil; Huffman, Derek M et al. (2014) Low insulin-like growth factor-1 level predicts survival in humans with exceptional longevity. Aging Cell 13:769-71
Ben-Shlomo, Shani; Einstein, Francine H; Zvibel, Isabel et al. (2012) Perinephric and epididymal fat affect hepatic metabolism in rats. Obesity (Silver Spring) 20:151-6
Knight, Colette M; Gutierrez-Juarez, Roger; Lam, Tony K T et al. (2011) Mediobasal hypothalamic SIRT1 is essential for resveratrol's effects on insulin action in rats. Diabetes 60:2691-700
Ben-Shlomo, Shani; Zvibel, Isabel; Shnell, Mati et al. (2011) Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase. J Hepatol 54:1214-23
Thompson, Reid F; Fazzari, Melissa J; Niu, Hongshun et al. (2010) Experimental intrauterine growth restriction induces alterations in DNA methylation and gene expression in pancreatic islets of rats. J Biol Chem 285:15111-8
Thompson, Reid F; Atzmon, Gil; Gheorghe, Ciprian et al. (2010) Tissue-specific dysregulation of DNA methylation in aging. Aging Cell 9:506-18
Einstein, Francine H; Huffman, Derek M; Fishman, Sigal et al. (2010) Aging per se increases the susceptibility to free fatty acid-induced insulin resistance. J Gerontol A Biol Sci Med Sci 65:800-8
Einstein, Francine; Thompson, Reid F; Bhagat, Tushar D et al. (2010) Cytosine methylation dysregulation in neonates following intrauterine growth restriction. PLoS One 5:e8887
Huffman, Derek M; Barzilai, Nir (2010) Contribution of adipose tissue to health span and longevity. Interdiscip Top Gerontol 37:1-19
Muzumdar, Radhika H; Huffman, Derek M; Atzmon, Gil et al. (2009) Humanin: a novel central regulator of peripheral insulin action. PLoS One 4:e6334

Showing the most recent 10 out of 35 publications